Associated Papers
Prospective clinical sequencing of 1016 Chinese prostate cancer patients: uncovering genomic characterization and race disparity.
Wei Y et al.
Molecular Oncology, 2023
37584393 (PubMed )
Supplement: MOL2-17-2183-s002.xlsx › Table_S14
Clinicopathological and molecular analysis of microsatellite instability in prostate cancer: a multi-institutional study in China.
Zhang H et al.
Frontiers in Oncology, 2023
Molecular features of exceptional response to neoadjuvant anti-androgen therapy in high-risk localized prostate cancer.
Tewari AK et al.
Cell Reports, 2021
Interfocal heterogeneity challenges the clinical usefulness of molecular classification of primary prostate cancer.
Carm KT et al.
Scientific Reports, 2019
31537872 (PubMed )
Supplement: 41598_2019_49964_MOESM1_ESM.pdf
SPOP and FOXA1 mutations are associated with PSA recurrence in ERG wt tumors, and SPOP downregulation with ERG-rearranged prostate cancer.
Hernández-Llodrà S et al.
The Prostate, 2019
Select a paper to view details